Reardon Andrew

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$1.21M

Insider Activity of Reardon Andrew

According to the SEC Form 4 filings, Reardon Andrew, being in a position of

  1. CLO & Secretary at Ligand Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 13500 shares for $1.19M,
    over all time since 2023-03-24, has bought 0 shares, and sold 13800 shares for $1.21M.

The largest sale of all time was on 2024-05-09 and amounted to 10000 shares of Ligand Pharmaceuticals Incorporated for $830,449.

Biography of Reardon Andrew

No biography is available at this moment.

2024-09-23SaleLigand Pharmaceuticals Incorporated
LGND
CLO & Secretary
2,000
0.0109%
$99.60$199,201+1.06%
2024-08-28SaleLigand Pharmaceuticals Incorporated
LGND
CLO & Secretary
1,500
0.0082%
$106.39$159,591-3.63%
2024-05-09SaleLigand Pharmaceuticals Incorporated
LGND
Chief Legal Officer &
10,000
0.0537%
$83.04$830,449+15.38%
2023-03-24SaleLigand Pharmaceuticals Incorporated
LGND
See Remarks
300
0.0018%
$69.92$20,977+2.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.